Assessment of Parkinson's disease risk loci in Greece
暂无分享,去创建一个
Hannah A. Pliner | D. Hernandez | M. Nalls | A. Singleton | N. Wood | S. Arepalli | G. Koutsis | M. Panas | H. Houlden | E. Dardiotis | G. Hadjigeorgiou | G. Xiromerisiou | L. Stefanis | Connor Edsall | M. Keller | M. Bozi | J. Hardy | E. Kara | Christopher Letson | L. Fidani | A. Plaitakis | S. Bostantjopoulou | Margaux F. Keller | C. Spanaki | S. Ralli | K. Kalinderi | J. Bras | Christopher T Letson
[1] Raffaella Casadei,et al. Meta-Analysis of Parkinson's Disease Transcriptome Data Using TRAM Software: Whole Substantia Nigra Tissue and Single Dopamine Neuron Differential Gene Expression , 2016, PloS one.
[2] E. Dietrichs,et al. Supportive evidence for 11 loci from genome-wide association studies in Parkinson's disease , 2013, Neurobiology of Aging.
[3] J. Stamatoyannopoulos,et al. A European population in Minoan Bronze Age Crete , 2013, Nature Communications.
[4] Vincenzo Bonifati,et al. The genetics of Parkinson's disease: Progress and therapeutic implications , 2013, Movement disorders : official journal of the Movement Disorder Society.
[5] K. Kidd,et al. Exploring Genomic Structure Differences and Similarities between the Greek and European HapMap Populations: Implications for Association Studies , 2012, Annals of human genetics.
[6] Sang Hong Lee,et al. Estimation of pleiotropy between complex diseases using single-nucleotide polymorphism-derived genomic relationships and restricted maximum likelihood , 2012, Bioinform..
[7] H. Houlden,et al. High frequency of the expanded C9ORF72 hexanucleotide repeat in familial and sporadic Greek ALS patients , 2012, Neurobiology of Aging.
[8] D. Hernandez,et al. Genome Wide Assessment of Young Onset Parkinson’s Disease from Finland , 2012, PloS one.
[9] B. Traynor. Road to the chromosome 9p-linked ALS/FTD locus , 2012, Journal of Neurology, Neurosurgery & Psychiatry.
[10] D. Vassilatis,et al. Evidence of an association between the scavenger receptor class B member 2 gene and Parkinson's disease , 2012, Movement disorders : official journal of the Movement Disorder Society.
[11] Chuong B. Do,et al. Comprehensive Research Synopsis and Systematic Meta-Analyses in Parkinson's Disease Genetics: The PDGene Database , 2012, PLoS genetics.
[12] Eden R Martin,et al. Meta‐analysis of Parkinson's Disease: Identification of a novel locus, RIT2 , 2012, Annals of neurology.
[13] Bruce L. Miller,et al. Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS , 2011, Neuron.
[14] David Heckerman,et al. A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD , 2011, Neuron.
[15] Nicholas Eriksson,et al. Web-Based Genome-Wide Association Study Identifies Two Novel Loci and a Substantial Genetic Component for Parkinson's Disease , 2011, PLoS genetics.
[16] D. Hernandez,et al. Genome-wide association study confirms extant PD risk loci among the Dutch , 2011, European Journal of Human Genetics.
[17] Simon C. Potter,et al. A Two-Stage Meta-Analysis Identifies Several New Loci for Parkinson's Disease , 2011, PLoS genetics.
[18] Natalie M. Myres,et al. The coming of the Greeks to Provence and Corsica: Y-chromosome models of archaic Greek colonization of the western Mediterranean , 2011, BMC Evolutionary Biology.
[19] P. Visscher,et al. Estimating missing heritability for disease from genome-wide association studies. , 2011, American journal of human genetics.
[20] Mohamad Saad,et al. Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies , 2011, The Lancet.
[21] Mohamad Saad,et al. Genome-wide association study confirms BST1 and suggests a locus on 12q24 as the risk loci for Parkinson's disease in the European population. , 2011, Human molecular genetics.
[22] P. Visscher,et al. GCTA: a tool for genome-wide complex trait analysis. , 2011, American journal of human genetics.
[23] L. Peltonen,et al. A multilocus genetic risk score for coronary heart disease: case-control and prospective cohort analyses. , 2010 .
[24] David Heckerman,et al. Chromosome 9p21 in amyotrophic lateral sclerosis in Finland: a genome-wide association study , 2010, The Lancet Neurology.
[25] P. Visscher,et al. Common SNPs explain a large proportion of the heritability for human height , 2010, Nature Genetics.
[26] Eden R Martin,et al. Genome‐Wide Association Study Confirms SNPs in SNCA and the MAPT Region as Common Risk Factors for Parkinson Disease , 2010, Annals of human genetics.
[27] Yusuke Nakamura,et al. Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease , 2009, Nature Genetics.
[28] Sonja W. Scholz,et al. Genome-Wide Association Study reveals genetic risk underlying Parkinson’s disease , 2009, Nature Genetics.
[29] K. Doheny,et al. Genomewide association study for susceptibility genes contributing to familial Parkinson disease , 2009, Human Genetics.
[30] Andrew B. Singleton,et al. Association between AKT1 gene and Parkinson's disease: A protective haplotype , 2008, Neuroscience Letters.
[31] J. Hardy,et al. Association of Tau Haplotype-Tagging Polymorphisms with Parkinson’s Disease in Diverse Ethnic Parkinson’s Disease Cohorts , 2007, Neurodegenerative Diseases.
[32] D. Reich,et al. Population Structure and Eigenanalysis , 2006, PLoS genetics.
[33] D. Reich,et al. Principal components analysis corrects for stratification in genome-wide association studies , 2006, Nature Genetics.
[34] G. Abecasis,et al. Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies , 2006, Nature Genetics.
[35] J. R. Gibbs,et al. Testing association between LRRK2 and Parkinson’s disease and investigating linkage disequilibrium , 2005, Journal of Medical Genetics.
[36] Guido Barbujani,et al. Y chromosomal haplogroup J as a signature of the post-neolithic colonization of Europe , 2004, Human Genetics.
[37] P. Underhill,et al. Origin, diffusion, and differentiation of Y-chromosome haplogroups E and J: inferences on the neolithization of Europe and later migratory events in the Mediterranean area. , 2004, American journal of human genetics.
[38] Toshihiro Tanaka. The International HapMap Project , 2003, Nature.
[39] E. Lander,et al. On the allelic spectrum of human disease. , 2001, Trends in genetics : TIG.
[40] Robert L. Nussbaum,et al. Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .
[41] W. Gibb,et al. THE SIGNIFICANCE OF THE LEWY BODY IN THE DIAGNOSIS OF IDIOPATHIC PARKINSON'S DISEASE , 1989, Neuropathology and applied neurobiology.
[42] W. Gibb,et al. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. , 1988, Journal of neurology, neurosurgery, and psychiatry.
[43] Simon C. Potter,et al. Using genome-wide complex trait analysis to quantify ‘ missing heritability ’ in Parkinson ’ s disease , 2012 .
[44] J. Kere,et al. Human population genetics: lessons from Finland. , 2001, Annual review of genomics and human genetics.
[45] T Varilo,et al. Molecular genetics of the Finnish disease heritage. , 1999, Human molecular genetics.
[46] S E Ide,et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. , 1997, Science.